Carrollton-based Swiss American CDMO and Irving’s BioNTX are joining forces to host the inaugural Biotechnology and Healthcare Industry Alliance of North Texas (BHIANT) launch meeting, in a bid to champion a next-generation, industry-led workforce partnership.
The partners said that Dallas-Fort Worth area employers will benefit from a skilled workforce that serves communities through high-paying, quality jobs in biotechnology, biomanufacturing, and industry related entry-level positions.
“The future success of this industry relies, in part, on the supply of both entry-level and long-term career pathways,” Dr. Aaron BenComo, director of business and industry for BioNTX, said in a statement. “So, working closely with Swiss American, Dallas College and our partner institutions, the BHIANT represents the industry-driven component of this sector-partnership.”
The inaugural BHIANT event will be held June 22 with Swiss American CDMO hosting in Carrollton at its 1540 Luna Road facility.
The alliance seeks to bring together industry trade and manufacturing ecosystems, the partners said. Swiss American is a drug and medical device Contract Development and Manufacturing Organization and BioNTX is a biotechnology trade organization.
Empowering biotech growth in North Texas
Swiss American said it will provide expertise and insights into the complexities of biotechnology in the manufacturing industry, which will help develop the best long-term strategies for attracting qualified employees that power biotech business growth in North Texas.
“We’re honored to be part of the BHIANT launch with BioNTX, Dallas College, and other distinguished partners,” Komel Grover, president and CEO of Swiss American, said in a statement. “Our company has been in the DFW area for over 30 years, and this alignment between trade group, advocacy, university systems, healthcare institutions, and business, specifically addressing biotechnology in North Texas, is a remarkable opportunity that has long been our vision for advancing our life sciences ecosystem.”
Swiss American CDMO said if delivers breakthrough innovation and superior manufacturing of topical solutions to global skin companies and personal care products including cosmetic, OTC drug, and medical device regulatory pathways.
Earlier this year, we told you about how Swiss American CDMO plans to use new “slippery surface technology” that allows customers to get literally everything out of its containers.
In 2020, Swiss American announced a new facility in Carrollton that included a new 131,760-square-foot space close to the company’s headquarters.
A bioscience and healthcare innovation trade organization in North Texas, BioNTX is an affiliate of the Biotechnology Innovation Organization in Washington, D.C. It’s a bridge between businesses and job opportunities, providing direct cost savings services, networking events, and educational programming to the bioscience and healthcare innovation community in North Texas.
Get on the list.
Dallas Innovates, every day.
Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.
R E A D N E X T
-
Swiss American CDMO specializes in the manufacture of topical skin care products. It announced an agreement with LiquiGlide, inventors of the EveryDrop dispensing platform, to deliver the "frictionless" coating tech for the global skin care market. "If a consumer spends $20 for a lotion, they should get $20 worth from the bottle," says Swiss American CDMO president and CEO Komel Grover.
-
Don't miss your chance to get our biggest-ever Dallas Innovates magazine. Request a complimentary copy of the once-a-year limited edition now.
-
Find your passion and give with purpose to support our community.
-
Here’s how your company could be named one of the most innovative, fastest-growing companies in North America. The prestigious Fast 500 rankings honor companies large and small, public and private. Time is ticking: Apply by June 23, 2023.
-
The once-a-year summit on September 22 and 23 is an innovation multiplier for capital, collaboration, and commercialization. Experts in the field will discuss strategy and exchange insights—and what's driving life science success across the region.
